Why is CVKD Down Today?

CVKD
$1.38
▼ -4.83% ($-0.07)
Last updated: Nov 12, 2026 8:30 PM ET

About Cadrenal Therapeutics, Inc. Common Stock

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardi...

Sector: PHARMACEUTICAL PREPARATIONS
Market Cap: $28.78M
Forward P/E: -2.4
52-Week Range: $0.82 - $12.50
Employees: 4

Overall Confidence: 65%

65% Confident

Based on news, social sentiment, options activity, and sector analysis

SYMPATHY 60% Confidence
🎯 Outperforming sector by 4.2%
This stock is significantly underperforming its PHARMACEUTICAL PREPARATIONS sector peers, suggesting a stock-specific catalyst.

✅ Move Confirmation

MODERATE VOLUME 1.2x average volume

NORMAL - This move is backed by significant volume and appears sustainable.

📍 Sector Context

PHARMACEUTICAL PREPARATIONS sector: -0.6%

CVKD is outperforming its sector by -4.2%. This suggests a stock-specific catalyst.

Market Comparison

CVKD is significantly underperforming the market (-4.5% vs SPY)
S&P 500
SPY
-0.33%
Nasdaq 100
QQQ
-0.41%
CVKD
This Stock
-4.83%
vs S&P 500: -4.5%
vs Nasdaq: -4.42%

📊 What Happens Next?

Probability Analysis

45% chance this move continues in the next 1-3 days

Expected Range

Based on historical patterns and options pricing, CVKD is expected to trade between:
$1.34 - $1.41

Key Level to Watch

$1.31 support
Watch for breakdown below $1.38

🔔 Get CVKD Alerts

We'll notify you when CVKD's trend changes or a new signal fires.

Last updated: Nov 12, 2026 8:30 PM (-324 minutes ago)
Data refreshes every 30 minutes during market hours

Historical Context

CVKD has moved more than 3.0% down on 94 occasions in the past year.

59.6%
Continuation Rate
56/94 times continued down
-0.63%
Avg Next Day Change
After similar down moves
Last similar move: Nov 05, 2026 (-5.7%) → Next day: -2.0%

Frequently Asked Questions

Why is CVKD stock down today?

This stock is significantly underperforming its PHARMACEUTICAL PREPARATIONS sector peers, suggesting a stock-specific catalyst.

Is CVKD stock a buy or sell right now?

Based on current analysis, CVKD shows 65% confidence in today's move. Volume is moderate which supports the trend. View full buy/sell analysis →

What is the CVKD stock price target?

CVKD is currently trading at $1.38. Based on today's momentum, the expected short-term range is $1.34 - $1.41. See long-term price prediction →

Will CVKD stock continue falling?

Our analysis shows a 45% probability that CVKD's move continues in the next 1-3 days. Key level to watch: $1.31 (support).

Is CVKD stock oversold or overbought?

CVKD's RSI (Relative Strength Index) is currently at 64.4. This shows bullish momentum - the stock has positive momentum but isn't overextended yet.

What is the momentum for CVKD stock?

CVKD's 10-day momentum indicator is at 0.44. Positive momentum - the stock has mild upward pressure supporting the current trend.

Is CVKD outperforming or underperforming the market?

CVKD (-4.83%) is currently significantly underperforming the market (-4.5% vs SPY). Today, the S&P 500 (SPY) is down -0.33%, and Nasdaq (QQQ) is down -0.41%.

What does MACD indicate for CVKD?

CVKD's MACD (0.07) is currently above the signal line (0.01), indicating a bullish trend. This technical signal suggests buying pressure is dominant. The trend strength (ADX: 27.2) is strong.

Is CVKD in an uptrend or downtrend?

Based on moving average analysis, CVKD is in a bullish trend. The price ($1.38) is trading above both the 20-day SMA ($1.09) and 50-day SMA ($1.08). This alignment typically indicates sustained upward momentum.

Check Why Another Stock is Moving

Enter any ticker symbol to see real-time analysis

Popular: AAPL TSLA NVDA MSFT META AMZN GOOGL